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【Abstract】 Objective:    To investigate the molecular
pathway of substance P (SP) to induce osteoblastic
differentiation.
Methods:    Mesenchymal stem cells were isolated and
cultured.  The cultures were divided into four groups with
Group A (control group) cultured without any factors, Group
B cultured with SP, Group C cultured with SP and SP receptor
neurokinin-1 (NK1) antagonist, and Group D cultured with
SP NK1 antagonist respectively to induce osteoblastic cells
differentiation. Osterix gene expression was detected by
reverse transcription-polymerase chain reaction (RT-PCR)
for three times after 1-2 weeks of cultivation and the results
were analyzed by one-way analysis of variance (ANOVA).
Results:    The log phase of bone marrow stromal cells
appeared at 4-6 days. ALP staining revealed that the major-
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ity of cells, more than 95%, were positive and small blue-
purple granules were found in the cytoplasm.  And Group B,
treated with SP, showed a higher level of ALP activity than
the other three groups. Meanwhile, RT-PCR found that
Osterix expression in Group B was obviously up-regulated,
compared with other groups. But Osterix expression in Group
D had no remarkable differences, compared with the controls.
Conclusions:    SP can up-regulate Osterix gene expres-
sion to stimulate differentiation of mesenchymal stem cells
into osteoblastic cells at the final stage. The regulatory ef-
fect of SP on Osterix expression was dependant on SP NK1
receptors.
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Neurons not only innervate skeletal muscles,but also function as the source of a networkinnervating cancellous bone.1 These osseal
neurons contain a variety of peripherally released
neurotransmitters, whose functional receptors have been
identified in bone cells.2 Substance P (SP) is a kind of
neurotransmitter widely distributed in the central and
peripheral nervous systems. Recent studies have re-
vealed that SP modulates osteoblastic bone formation
through neurokinin-1 receptors (NK1-Rs). Neuropeptide
SP functions as a neurotransmitter of nociceptive
messages. It is synthesized in unmyelinated sensory
neurons and released from their peripheries.3 Several
investigators have reported that SP is associated with
bone metabolism, including osteoblastic bone forma-
tion and osteoclastic bone absorption.4 Previous stud-
ies agree on the stimulatory effects of SP on osteo-
clastic absorption of bones. But the effects of SP on
osteoblastic bone formation are still unclear. Some
studies have reported that SP stimulated osteogenesis
in a dose-dependent manner.5 But on the other hand,
some reports suggested that SP inhibits osteoblastic
cell differentiation in rat calvarial osteoblastic cells.6
Previous studies indicated that NK1-Rs distribute on
osteoblasts. Latest studies demonstrated that SP NK1-Rs
are expressed in calvarial osteoblastic cells at the late
stage of cell differentiation.7 But the specific molecular
targets of SP on modulation of bone formation are still
unclear. Here we hypothesized that SP plays an im-
portant role in the process of mesenchymal stem cells
differentiation into osteoblast cells. Assessing Osterix
expression levels will help to gain a better understand-
ing of the precise effects of SP on modulation of osteo-
blastic cell differentiation.
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METHODS
Isolation and harvest of bone marrow stromal cells
Rat mesenchymal stem cells were isolated from
the bone marrow of femoral and tibial medullary cavi-
ties of 100 g Wistar rats, and flushed using ice-cold L-
DMEM (Gibco, USA) supplemented with 10% fetal bo-
vine serum (FBS, Hyclone, USA). Then the flushed
marrow cell suspension was beat repeatedly through a
22-gauge needle and filtered through a 100 µm cell strainer
before culture. Marrow cells were plated in 25 cm2 tissue
culture flasks with a proper number of 1×106-1×107 cells/
ml. The cultures were incubated at 37°C in a humidified
incubator containing 5% CO2. The media were supple-
mented with L-DMEM, 10% FBS, 100 IU/ml penicillin,
100 µg/ml streptomycin, 1 µg/ml amphotericin and 0.3
mmol ascorbic acid (Amresco, USA) and changed every
other day.
Monolayer culture
When the cell confluence reached 80%, cells were
passaged with 0.02% trypsin (Gibco, USA) in PBS and
transferred to new culture flasks in a ratio of 1:3. The
cells were cultured in 24-well culture plates at 37°C in
a humidified atmosphere containing 5% CO2. After 3
passages of monolayer culture, these cultures were
divided into four groups: Group A, the control group,
incubated without additional factors; Group B, incubated
with SP (10 µmol, Sigma S6883, USA); Group C, incu-
bated with a mixture of SP and NK1 antagonist (10 µmol,
Sigma A5330, USA); and Group D, incubated with NK1
antagonist (10 µmol). All groups were cultured for 14
days.
Alkaline phosphatase (ALP) staining and ALP activity
ALP staining was performed to identify osteoblasts.
After 3 passages of monolayer culture, cells were
stained with ALP dye liquor. And the percentages of
ALP positive cells were counted.
ALP activity was determined as described by Hirata et
al8 previously. For histochemical detection of ALP
activity, the cells were fixed for 15 minutes with 10%
neutral buffered formalin and then incubated with a mix-
ture of 0.1 mg/ml naphthol AS-MXphosphate (Fermentas,
USA), 0.5% N-dimethyI-formamide, 2 mmol MgCl2, and
0.6 mg/ml fast blue BB salt in 0.1 mol tris-HCl (Sigma
Chem, USA) under the condition of room temperature
and pH=8.5. ALP activity was determined using p-nitro
-phenylphosphate as a substrate in 50 mmol 2-amino-
2-methylpropanol and 2 mmol MgCl2 at pH=10. The
amount of p-nitro-phenylphosphate released was esti-
mated by measuring absorbance at 410 nm. Protein
concentration was determined using a BCA protein
assay kit (Fermentas, USA).
Reverse transcription-polymerase chain reaction
(RT-PCR)
  Expression levels of the transcription factor,
Osterix, were determined by RT-PCR. Osteoblastic cells
were cultured for 14 days in media without any addi-
tional factors (Group A), or with SP (Group B), or SP
combined with NK1 antagonist (Group C), or NK1 an-
tagonist (Group D), as mentioned previously. Cellular
mRNA was extracted using a total RNA extraction
miniprep system (Shanghai Bio-engineering Limited
Company, China) according to the manufacturer’s
instruction. To reduce DNA contamination, the RNA
samples were treated with RNase-free DnaseI
(Fermentas, USA) for 3 hours at 37°C and cDNA was
synthesized from 2 µg total RNA in 30 µl reaction buffer
composed of 500 µg dNTPs, 20 U ribonuclease inhibitor,
and 200 U superscript II reverse transcriptase. The
primer sequences used for amplification were as follows:
mouse β -actin 5’ primer, CTA CAA TGA GCT GCG
TGT GGC; mouse β-actin 3’ primer, CAG GTC CAG
ACG GAT GGC; mouse Osterix 5’ primer, CTG GGA
AAA GGA GGC ACA AAG AA; and mouse Osterix 3’
primer, GGCAAA GTC AGA CGG GTA AGT AG. Each
cycle consisted of denaturation at 94°C for 30 seconds,
annealing at 54°C for 30 seconds and 72°C for 30
seconds, 36 cycles in all. We replicated the RT-PCR
for three times. Each PCR mixture consisted of cDNA,
taq polymerase buffer (Fermentas, USA), 1 µl sense
primers and 1 µl anti-sense primers, with a total volume
of 50 µl. The PCR products were electrophoresed in 1.5%
agarose gels and visualized with ethidium bromide.
Statistical analysis
Data on conditions of each culture were analyzed
using SPSS 12.0 statistical software to determine if
the differences among groups were statistically
significant. The values were expressed as mean ± stan-
dard deviation (SD). We performed a one-way analysis
of variance (ANOVA) to compare the means. Compari-
sons among groups were made using the least signifi-
cant difference t test and the differences were consid-
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RESULTS
Osteoblastic cells differentiation and proliferation
After 4-5 days of culture, bone marrow stromal cells
appeared spindle-shaped, triangular or polygonal. They
covered the plate surface, formed extensive cell sheets
in every group after 11-12 days of culture, and then were
induced differentiation into osteoblasts. After about 3
passages, the cells were cultured in 24-well culture
plates, and the number of cells was counted every 3
wells each day. Proliferation of bone marrow stromal
cells increased slowly on 1-4 days, but achieved a rapid
increase at 4-7 days. With or without SP, proliferation
and differentiation of osteoblasts had no remarkable
differences between Group A and Group B, all appear-
ing the characteristic spindle or triangular shapes of
differentiating osteoblasts (Figure 1). SP treatment did
not affect osteoblast proliferation or differentiation.
ALP staining and ALP activity
ALP staining was performed to identify osteoblasts.
The majority of cells, more than 95%, were positive.
Small blue-purple granules were found in their cyto-
plasm (Figure 2). Meanwhile, the degree of osteoblas-
tic differentiation of the cells was evaluated by deter-
mining the ALP activity since it was one of the markers.
Osteoblastic cells were seeded on 24-well culture plates
and ALP activities were measured 14 days later in cul-
tures with or without SP or SP NK1 antagonist. During
the period of cultivation,  all the four groups had osteo-
blastic cells showing a positive ALP activity. However,
Group B treated with SP showed an increased ALP
activity throughout the period of cultivation. Group C
and Group D, treated with SP plus NK1 antagonist or
NK1 antagonist, have not shown a higher level of ALP
activity, compared with the control group (Figure 3).
Effects of SP on Osterix expression by RT-PCR
Effects of SP on the differentiation of mesenchymal
stem cells were examined by measuring the expres-
sion of Osterix in osteoblastic cells cultured for 14 days.
Osterix was an essential transcription factor that regu-
lates osteoblast differentiation. It played a crucial role
at the final step in the differentiation of osteogensis. In
our study, Osterix mRNA expression apparently in-
creased on Day 14, which was affected by SP. The
expression of Osterix in Group B, treated with SP (10
µmol) had a significant difference, compared with other
Figure 1. A: Mesenchymal stem cell monolayer cultured for 14 days without any factors (×40). B: Mesenchymal stem cell monolayer
cultured for 14 days with 10 µmol SP (×40). Figure 2. Mesenchymal stem cell monolayer cultured for 14 days (ALP staining×200). We can
see that most cells are positive with small blue-purple granules in their cytoplasm.
 Figure 4. RT-PCR analysis of Osterix expression on Day 14. The
expression of Osterix in Group B, treated with 10 µmol SP,  is up-
regulated compared with other groups.
Figure 3.  ALP activity of the four groups detected by RT-PCR 14
days after culture. Group B treated with SP shows a higher level
of ALP activity than the other three groups.
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DISCUSSION
Osteoblasts are derived from undifferentiated mes-
enchymal stem cells, which are the common progeni-
tor of chondrocytes, adipocytes and myotubes.9,10 In
vitro  experiments have provided important information
regarding the regulatory mechanism of osteoblast dif-
ferentiation from mesenchymal stem cells.11 The dis-
covery of several regulators in pluripotent mesenchy-
mal cells has shown that cell differentiation is critically
controlled by the level of gene transcription. Transcrip-
tion factors that determine the differentiation pathways
of specific cell types have been identified in several cell
lineages. For example, Osterix, a novel zinc-finger-con-
taining transcription factor, has been identified ex-
pressed specifically in osteoblasts, consistent with its
localized expression. Osterix-deficient mice show a
complete lack of bone mineralization.12 Therefore, the
absence of Osterix expression in Runx2-deficient mice
could be explained in terms of sequential expression of
transcription factors in osteoblast differentiation.
Whereas the final differentiation markers of osteoblast,
such as osteocalcin expression, is induced by Osterix
rather than Runx2.12 The findings propose that Osterix
plays a crucial role at the final step of osteoblast
differentiation.
   It has been proposed that neuropeptide SP can
modulate bone remodeling. Previous studies have dem-
onstrated the effects of SP on osteoblasts. Shih and
Bernard5 found that SP had a dose-related osteogenic
stimulating effect, and suggested that the effect was
most likely caused by the stimulation of stem cell
mitosis, osteoprogenitor cell differentiation and osteo-
blastic activity. But the expression of SP receptor in
osteoblastic cells is very debatable. Some studies dem-
onstrated that SP receptors were unable to be detected
in human periosteum-derived osteoblastic cells and
human osteosarcoma-derived cells.13 Recently Goto et
al7 reported that NK1-Rs, SP receptors, are expressed
in calvarial osteoblastic cells at the late stage of cell
differentiation, but not at the early stage. In our
experiment, mesenchymal stem cells were isolated,
and then cultured without factors, with SP, with SP
and NK1 antagonist, or with NK1 antagonist, respectively.
ALP is a marker for the early stage of osteoblastic cells
differentiation. In vitro studies have shown that expres-
sions of ALP increase with the differentiation of osteo-
blastic cells.14 In addition, a number of factors have been
shown to regulate ALP activity in bone-forming cells.
Among these factors, epinephrine was recently found
to enhance DNA synthesis and ALP activity in growing
and differentiating MC3T3-E1 osteoblast-like cells,
respectively.15 ALP activity was determined in our study
and we found that SP enhanced ALP activity in differ-
entiating osteoblastic cells.
RT-PCR analysis of the expression levels of Osterix
mRNA in osteoblastic cells was made 14 days after
culture. Optical density values of quantitative RT-PCR
analysis on Osterix expression were replicated for three
times. We found that treatment with 10 µmol SP stimu-
lated differentiation of osteoblastic cells cultured for 14
days through up-regulating expression of Osterix.
Meanwhile, 10 µmol SP combined with 10 µmol SP
NK1 antagonist did not stimulated Osterix mRNA
expression, which indicated that the stimulatory effect
of SP was dependent on NK1-Rs.
In conclusion, we demonstrate that neuropeptide
SP stimulates osteoblastic activity at the final differen-
tiation stage in osteogensis through up-regulating ex-
pression of Osterix. Our data point to a role for SP in
the late stage of osteoblast differentiation from mesen-
chymal stem cells. These results clarify the role of SP
in the osteoblastic differentiation process at the mo-
lecular level, and will hopefully provide a basis for future
studies on links between the nervous system and bone
formation.
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